| pubmed-article:18095077 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0278701 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0995188 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:18095077 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:18095077 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18095077 | pubmed:dateCreated | 2007-12-20 | lld:pubmed |
| pubmed-article:18095077 | pubmed:abstractText | The aim of the study was to evaluate whether the therapy-induced reduction of the (18)F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) maximum standardized uptake value in patients with advanced gastric adenocarcinoma treated with chemotherapy plus cetuximab could predict the objective response and outcome early during the treatment. | lld:pubmed |
| pubmed-article:18095077 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18095077 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18095077 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18095077 | pubmed:issn | 1436-3291 | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:FantiStefanoS | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:PintoCarmineC | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:CastellucciPa... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:GiaquintaStef... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:FunaioliChiar... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:MutriVitaV | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:MartoniAndrea... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:Rojas... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:LongobardiCir... | lld:pubmed |
| pubmed-article:18095077 | pubmed:author | pubmed-author:SperandiFranc... | lld:pubmed |
| pubmed-article:18095077 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18095077 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:18095077 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18095077 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18095077 | pubmed:pagination | 221-7 | lld:pubmed |
| pubmed-article:18095077 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:meshHeading | pubmed-meshheading:18095077... | lld:pubmed |
| pubmed-article:18095077 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:18095077 | pubmed:articleTitle | The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab. | lld:pubmed |
| pubmed-article:18095077 | pubmed:affiliation | Medical Oncology Unit, S. Orsola-Malpighi Hospital, Via Albertoni, 15-40138, Bologna, Italy. | lld:pubmed |
| pubmed-article:18095077 | pubmed:publicationType | Journal Article | lld:pubmed |
